{"id":"https://openalex.org/W1994032445","doi":"https://doi.org/10.3310/hta9210","title":"Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study","display_name":"Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study","alternate_titles":[],"publication_year":2005,"publication_date":"2005-05-01","ids":{"openalex":"https://openalex.org/W1994032445","doi":"https://doi.org/10.3310/hta9210","mag":"1994032445","pmid":"https://pubmed.ncbi.nlm.nih.gov/15899149"},"language":"en","primary_location":{"id":"doi:10.3310/hta9210","doi":"https://doi.org/10.3310/hta9210","is_oa":true,"landing_page_url":"https://doi.org/10.3310/hta9210","pdf_url":"https://njl-admin.nihr.ac.uk/document/download/2004971","source":{"id":"https://openalex.org/S191206091","display_name":"Health Technology Assessment","issn_l":"1366-5278","issn":["1366-5278","2046-4924","2046-4932"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311817","host_organization_name":"NIHR Journals Library","host_organization_lineage":["https://openalex.org/P4310311817"],"host_organization_lineage_names":["NIHR Journals Library"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Technology Assessment","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1994032445"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://njl-admin.nihr.ac.uk/document/download/2004971","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020470458","display_name":"R Woodroffe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R Woodroffe","raw_affiliation_strings":["Department of Public Health and Epidemiology, University of Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Public Health and Epidemiology, University of Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019727393","display_name":"Guiqing Yao","orcid":"https://orcid.org/0000-0002-9095-6676","observed_orcids":["https://orcid.org/0000-0002-9095-6676","https://orcid.org/0000-0002-0591-9636"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G Yao","raw_affiliation_strings":["Health Economics Facility, Health Services Management Centre, University of Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics Facility, Health Services Management Centre, University of Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000134510","display_name":"Catherine Meads","orcid":"https://orcid.org/0000-0002-2368-0665","observed_orcids":["https://orcid.org/0000-0002-2368-0665"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C Meads","raw_affiliation_strings":["Department of Public Health and Epidemiology, University of Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Public Health and Epidemiology, University of Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107302454","display_name":"Susan E Bayliss","orcid":"https://orcid.org/0000-0003-3025-9323","observed_orcids":["https://orcid.org/0000-0003-3025-9323"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S Bayliss","raw_affiliation_strings":["Department of Public Health and Epidemiology, University of Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Public Health and Epidemiology, University of Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111589366","display_name":"A. Ready","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799307867","display_name":"Queen Elizabeth Hospital Birmingham","ror":"https://ror.org/048emj907","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049","https://openalex.org/I2799307867"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A Ready","raw_affiliation_strings":["Department of Nephrology, Queen Elizabeth Hospital, Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology, Queen Elizabeth Hospital, Birmingham, UK","institution_ids":["https://openalex.org/I2799307867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072495356","display_name":"James P. Raftery","orcid":"https://orcid.org/0000-0003-1094-8578","observed_orcids":["https://orcid.org/0000-0003-1094-8578"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J Raftery","raw_affiliation_strings":["Health Economics Facility, Health Services Management Centre, University of Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics Facility, Health Services Management Centre, University of Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043944967","display_name":"R. S. Taylor","orcid":"https://orcid.org/0000-0002-3043-6011","observed_orcids":["https://orcid.org/0000-0002-3043-6011"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"R Taylor","raw_affiliation_strings":["Department of Public Health and Epidemiology, University of Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Public Health and Epidemiology, University of Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5043944967"],"corresponding_institution_ids":["https://openalex.org/I79619799"],"apc_list":null,"apc_paid":null,"fwci":1.6755,"has_fulltext":true,"cited_by_count":213,"citation_normalized_percentile":{"value":0.82105263,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"9","issue":"21","first_page":"1","last_page":"179"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kidney-transplantation","display_name":"kidney transplantation","score":0.8659999966621399},{"id":"https://openalex.org/keywords/immunosuppressive-drugs","display_name":"immunosuppressants","score":0.8429999947547913},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9589999914169312},{"id":"https://openalex.org/keywords/basiliximab","display_name":"basiliximab","score":0.906000018119812},{"id":"https://openalex.org/keywords/daclizumab","display_name":"daclizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":0.996999979019165},{"id":"https://openalex.org/keywords/mycophenolate-mofetil","display_name":"mycophenolate mofetil","score":0.9449999928474426},{"id":"https://openalex.org/keywords/mycophenolate-sodium","display_name":"mycophenolate sodium","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":1.0},{"id":"https://openalex.org/keywords/acute-rejection","display_name":"acute rejection","score":0.6690000295639038},{"id":"https://openalex.org/keywords/graft-loss","display_name":"graft loss","score":0.8539999723434448},{"id":"https://openalex.org/keywords/patient-survival","display_name":"patient survival","score":0.9340000152587891},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.9459999799728394},{"id":"https://openalex.org/keywords/okt3","display_name":"OKT3","score":0.9089999794960022},{"id":"https://openalex.org/keywords/induction-therapy","display_name":"induction therapy","score":0.7369999885559082},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.7129999995231628},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5440000295639038},{"id":"https://openalex.org/keywords/economic-evaluation","display_name":"economic evaluation","score":0.3569999933242798}],"concepts":[{"id":"https://openalex.org/C2781307858","wikidata":"https://www.wikidata.org/wiki/Q418702","display_name":"Basiliximab","level":4,"score":0.9268380999565125},{"id":"https://openalex.org/C2779719350","wikidata":"https://www.wikidata.org/wiki/Q412920","display_name":"Daclizumab","level":4,"score":0.9262605309486389},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.920868992805481},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.6330379247665405},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.6000059247016907},{"id":"https://openalex.org/C2779528694","wikidata":"https://www.wikidata.org/wiki/Q367700","display_name":"Ciclosporin","level":3,"score":0.5270669460296631},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4814252555370331},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.47535842657089233},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.44110843539237976},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.4272758364677429},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3557184934616089},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.09351474046707153},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077552","descriptor_name":"Basiliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077561","descriptor_name":"Daclizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006084","descriptor_name":"Graft Rejection","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006084","descriptor_name":"Graft Rejection","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009173","descriptor_name":"Mycophenolic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D009173","descriptor_name":"Mycophenolic Acid","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D009173","descriptor_name":"Mycophenolic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016030","descriptor_name":"Kidney Transplantation","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D016030","descriptor_name":"Kidney Transplantation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016030","descriptor_name":"Kidney Transplantation","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017059","descriptor_name":"Models, Econometric","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3310/hta9210","doi":"https://doi.org/10.3310/hta9210","is_oa":true,"landing_page_url":"https://doi.org/10.3310/hta9210","pdf_url":"https://njl-admin.nihr.ac.uk/document/download/2004971","source":{"id":"https://openalex.org/S191206091","display_name":"Health Technology Assessment","issn_l":"1366-5278","issn":["1366-5278","2046-4924","2046-4932"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311817","host_organization_name":"NIHR Journals Library","host_organization_lineage":["https://openalex.org/P4310311817"],"host_organization_lineage_names":["NIHR Journals Library"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Technology Assessment","raw_type":"journal-article"},{"id":"pmid:15899149","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15899149","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health technology assessment (Winchester, England)","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:943dfffe7c224b4bb795a242569af93b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/943dfffe7c224b4bb795a242569af93b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Health Technology Assessment, Vol 9, Iss 21 (2005)","raw_type":"article"},{"id":"pmh:oai:eprints.soton.ac.uk:372023","doi":null,"is_oa":false,"landing_page_url":"https://eprints.soton.ac.uk/372023/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401019","display_name":"ePrints Soton (University of Southampton)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I43439940","host_organization_name":"University of Southampton","host_organization_lineage":["https://openalex.org/I43439940"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.3310/hta9210","doi":"https://doi.org/10.3310/hta9210","is_oa":true,"landing_page_url":"https://doi.org/10.3310/hta9210","pdf_url":"https://njl-admin.nihr.ac.uk/document/download/2004971","source":{"id":"https://openalex.org/S191206091","display_name":"Health Technology Assessment","issn_l":"1366-5278","issn":["1366-5278","2046-4924","2046-4932"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311817","host_organization_name":"NIHR Journals Library","host_organization_lineage":["https://openalex.org/P4310311817"],"host_organization_lineage_names":["NIHR Journals Library"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Technology Assessment","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4322203783","display_name":null,"funder_award_id":"01/59/01","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G7626999565","display_name":null,"funder_award_id":"01/59/01","funder_id":"https://openalex.org/F4320334661","funder_display_name":"Health Technology Assessment Programme"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320320339","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70"},{"id":"https://openalex.org/F4320334661","display_name":"Health Technology Assessment Programme","ror":"https://ror.org/0187kwz08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1994032445.pdf","grobid_xml":"https://content.openalex.org/works/W1994032445.grobid-xml"},"referenced_works_count":138,"referenced_works":["https://openalex.org/W76411232","https://openalex.org/W1552758461","https://openalex.org/W1583559519","https://openalex.org/W1756759934","https://openalex.org/W1906296259","https://openalex.org/W1916860342","https://openalex.org/W1966250111","https://openalex.org/W1969997949","https://openalex.org/W1973645636","https://openalex.org/W1974794773","https://openalex.org/W1978952701","https://openalex.org/W1979768246","https://openalex.org/W1982538695","https://openalex.org/W1985137297","https://openalex.org/W1986215651","https://openalex.org/W1990539832","https://openalex.org/W1990612749","https://openalex.org/W1991374011","https://openalex.org/W1992158831","https://openalex.org/W1993758901","https://openalex.org/W1997112680","https://openalex.org/W1998099663","https://openalex.org/W2000174571","https://openalex.org/W2002737967","https://openalex.org/W2003329996","https://openalex.org/W2003952289","https://openalex.org/W2005100496","https://openalex.org/W2006537941","https://openalex.org/W2006752458","https://openalex.org/W2006837550","https://openalex.org/W2013283804","https://openalex.org/W2013970018","https://openalex.org/W2015462253","https://openalex.org/W2015693061","https://openalex.org/W2016210923","https://openalex.org/W2018260129","https://openalex.org/W2021937222","https://openalex.org/W2023095312","https://openalex.org/W2023304075","https://openalex.org/W2024051360","https://openalex.org/W2027371366","https://openalex.org/W2029549907","https://openalex.org/W2031213157","https://openalex.org/W2031260579","https://openalex.org/W2031412970","https://openalex.org/W2032611005","https://openalex.org/W2033681223","https://openalex.org/W2036375887","https://openalex.org/W2037857651","https://openalex.org/W2039682092","https://openalex.org/W2039900989","https://openalex.org/W2040187737","https://openalex.org/W2042057092","https://openalex.org/W2042241032","https://openalex.org/W2044600432","https://openalex.org/W2045137114","https://openalex.org/W2047179014","https://openalex.org/W2047723007","https://openalex.org/W2047905046","https://openalex.org/W2048279888","https://openalex.org/W2048571115","https://openalex.org/W2048668600","https://openalex.org/W2051034684","https://openalex.org/W2052300623","https://openalex.org/W2052446271","https://openalex.org/W2052469928","https://openalex.org/W2055704616","https://openalex.org/W2056109287","https://openalex.org/W2056731689","https://openalex.org/W2060934462","https://openalex.org/W2062430887","https://openalex.org/W2063208585","https://openalex.org/W2064263299","https://openalex.org/W2064287642","https://openalex.org/W2065496914","https://openalex.org/W2065619982","https://openalex.org/W2066925307","https://openalex.org/W2067307123","https://openalex.org/W2074392022","https://openalex.org/W2076597593","https://openalex.org/W2078421689","https://openalex.org/W2080339151","https://openalex.org/W2080435221","https://openalex.org/W2080520275","https://openalex.org/W2082474321","https://openalex.org/W2084549330","https://openalex.org/W2086419710","https://openalex.org/W2089268585","https://openalex.org/W2089279921","https://openalex.org/W2090588399","https://openalex.org/W2092022334","https://openalex.org/W2094502740","https://openalex.org/W2102882632","https://openalex.org/W2106395444","https://openalex.org/W2106888919","https://openalex.org/W2111196252","https://openalex.org/W2112595386","https://openalex.org/W2113576725","https://openalex.org/W2115533710","https://openalex.org/W2121363636","https://openalex.org/W2122083735","https://openalex.org/W2122566299","https://openalex.org/W2123670789","https://openalex.org/W2123720448","https://openalex.org/W2124518557","https://openalex.org/W2124873371","https://openalex.org/W2130118821","https://openalex.org/W2136817040","https://openalex.org/W2138354430","https://openalex.org/W2146242635","https://openalex.org/W2148724358","https://openalex.org/W2165948787","https://openalex.org/W2168563215","https://openalex.org/W2169639894","https://openalex.org/W2294683143","https://openalex.org/W2312582843","https://openalex.org/W2312735169","https://openalex.org/W2320742659","https://openalex.org/W2320765101","https://openalex.org/W2329115280","https://openalex.org/W2334394267","https://openalex.org/W2336236972","https://openalex.org/W2397469461","https://openalex.org/W2415973664","https://openalex.org/W2466187856","https://openalex.org/W2493886745","https://openalex.org/W2609602266","https://openalex.org/W2740416820","https://openalex.org/W2990776223","https://openalex.org/W4211244373","https://openalex.org/W4230996310","https://openalex.org/W4247649808","https://openalex.org/W4252727071","https://openalex.org/W4402939499","https://openalex.org/W6634870798","https://openalex.org/W6834468207","https://openalex.org/W7043644746","https://openalex.org/W7062409307"],"related_works":["https://openalex.org/W1979658236","https://openalex.org/W2513290985","https://openalex.org/W2164580719","https://openalex.org/W2088725573","https://openalex.org/W2045601095","https://openalex.org/W1943037754","https://openalex.org/W2515342468","https://openalex.org/W188514265","https://openalex.org/W2607547730","https://openalex.org/W2006823435"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"examine":[2],"the":[3,9,45,50,55,99,119,204,254,269,296,325,374,394,410,424,431,469,505,538,555,559,569,585,602,608,611,639,644,660,692,700,707,721,745,776,807,824,831,835,841],"clinical":[4,640,681,740,868],"effectiveness":[5],"and":[6,21,23,81,105,247,259,301,320,365,380,403,421,430,440,454,465,488,618,629,641,682,742,750,789,811,830,869,872],"cost-effectiveness":[7,63,557,642],"of":[8,49,101,139,184,207,237,257,271,299,345,376,396,401,412,426,471,484,507,518,540,542,558,561,580,598,606,610,625,631,638,659,671,680,702,706,709,711,720,733,747,761,766,778,799,802,809,816,826,843],"newer":[10,459,612,645],"immunosuppressive":[11,479,736],"drugs":[12,327,461,509,544,737,779],"for":[13,58,245,433,674,796,822,861],"renal":[14,782,856],"transplantation:":[15],"basiliximab,":[16,485],"daclizumab,":[17,463,486],"tacrolimus,":[18],"mycophenolate":[19,265,315],"(mofetil":[20],"sodium)":[22],"sirolimus.":[24],"DATA":[25],"SOURCES:":[26],"Electronic":[27],"databases.":[28],"Industry":[29],"submissions.":[30],"Current":[31],"Clinical":[32,59],"Trials":[33],"register.":[34],"Cochrane":[35],"Collaboration":[36],"Renal":[37],"Disease":[38],"Group.":[39],"REVIEW":[40],"METHODS:":[41],"The":[42,137,182,233,398,458,481,563,623,657,685,764],"review":[43,705,726],"followed":[44],"InterTASC":[46],"standards.":[47],"Each":[48],"five":[51],"company":[52],"submissions":[53],"to":[54,145,159,164,193,212,225,242,292,318,347,358,406,452,513,545,552,687,775,833],"National":[56],"Institute":[57],"Excellence":[60],"(NICE)":[61],"contained":[62],"models,":[64],"which":[65],"were":[66,250,310,383,448],"evaluated":[67],"by":[68],"using":[69,759],"a":[70,77,348,359,493,546,678,703,716,773,794],"critique":[71],"covering":[72],"(1)":[73],"model":[74,79,83],"checking,":[75],"(2)":[76],"detailed":[78],"description":[80],"(3)":[82],"rerunning.":[84],"RESULTS:":[85],"For":[86,195,409],"induction":[87],"therapy,":[88,197],"three":[89,415],"randomised":[90],"controlled":[91],"trials":[92,564,758,768],"(RCTs)":[93],"found":[94,149,200,263],"that":[95,150,201,264,343,418],"daclizumab":[96,142],"significantly":[97,152,190,385],"reduced":[98,143,203,268,468],"incidence":[100,138,183,206,270,375,395,425,470],"biopsy-confirmed":[102,155],"acute":[103,156,209,234,272,330,354,377,413,428,474,499,527,575,666,689],"rejection":[104,157,210,235,331,429,475,500,528,576,667,690],"patient":[106,129,177,231,280,335,381,619,863,873],"survival":[107,130,178,281,336,382,620],"at":[108,134,285],"6":[109],"months/1":[110],"year":[111],"compared":[112,117,144,158,163,192,211,314,476,530],"with":[113,118,141,186,308,368,387,477,492,520,531,534,584,589,772],"placebo,":[114,160],"but":[115,161],"not":[116,162,189,384,511,566],"monoclonal":[120],"antibody":[121],"OKT3.":[122,146,168],"There":[123,169,214,249,274,290],"was":[124,170,188,215,275,490,523,550,697],"no":[125,171,216,276,322],"significant":[126,172,217,277],"gain":[127,173],"in":[128,174,219,253,279,295,328,356,370,444,497,526,571,595,691,694,724],"or":[131,167,179,222,230,282,287,337,578,669],"graft":[132,180,228,283,333,581,616,672,713],"loss":[133,229,284,617],"3":[135],"years.":[136],"side-effects":[140,185],"Eight":[147],"RCTs":[148,199,262,305,341,416,722],"basiliximab":[151,187],"improved":[153,797],"6-month/1-year":[154,205],"either":[165,175,220,388],"ATG":[166],"1-year":[176,221,286,329,353,498],"loss.":[181],"different":[191,386],"OKT3/ATG.":[194],"initial/maintenance":[196,350,371],"13":[198],"tacrolimus":[202,238,258,420,453,464,487,519],"biopsy-proven":[208],"ciclosporin.":[213,260],"improvement":[218,570],"long-term":[223,615,627,712,836],"(up":[224],"5":[226],"years)":[227,447],"survival.":[232],"benefit":[236,517],"over":[239],"ciclosporin":[240,360,451],"appeared":[241,291],"be":[243,293,407,514,754,770],"equivalent":[244],"Sandimmun":[246],"Neoral.":[248],"important":[251],"differences":[252,294],"side-effect":[255,297,338,399,586],"profile":[256,587],"Seven":[261],"mofetil":[266],"(MMF)":[267],"rejection.":[273,378],"difference":[278,323],"3-year":[288],"follow-up.":[289],"profiles":[298,400],"MMF":[300,307,319,422,489,522],"azathioprine":[302,367,402],"(AZA).":[303],"No":[304],"comparing":[306,450],"AZA":[309],"identified.":[311],"One":[312],"RCT":[313,439],"sodium":[316],"(MPS)":[317],"reported":[321],"between":[324],"two":[326],"rate,":[332],"survival,":[334],"profile.":[339],"Two":[340],"suggest":[342],"addition":[344,539,560],"sirolimus":[346,369,389,392,404],"ciclosporin-based":[349],"therapy":[351,363,372],"reduces":[352,373],"rejections":[355],"comparison":[357],"(Neoral)":[361],"dual":[362],"alone":[364],"substituting":[366],"Graft":[379],"regimen.":[390],"Adding":[391],"increases":[393],"side-effects.":[397],"appear":[405,512],"different.":[408],"treatment":[411],"rejection,":[414],"suggested":[417],"both":[419,626,739],"reduce":[423],"subsequent":[427],"need":[432,795,832],"additional":[434],"drug":[435,828],"therapy.":[436,480],"Only":[437,715],"one":[438,441,541],"subgroup":[442],"analysis":[443],"children":[445],"(<18":[446],"identified":[449,723],"sirolimus,":[455],"respectively.":[456],"CONCLUSIONS:":[457],"immunosuppressant":[460,548,866],"(basiliximab,":[462],"MMF)":[466],"consistently":[467],"short-term":[472,572,654,663],"(1-year)":[473],"conventional":[478],"independent":[482],"use":[483,688,825,842],"associated":[491,588],"similar":[494],"absolute":[495],"reduction":[496,525,533],"rate":[501,529,577,668],"(approximately":[502],"15%).":[503],"However,":[504],"effects":[506],"these":[508,543,748],"did":[510,565],"additive":[515],"(e.g.":[516,574,665],"adjuvant":[521,535],"5%":[524],"15%":[532],"AZA).":[536],"Thus,":[537],"baseline":[547],"regimen":[549],"likely":[551],"affect":[553],"adversely":[554],"incremental":[556],"another.":[562],"assess":[567,834],"how":[568],"outcomes":[573,729,871],"measures":[579,670],"function),":[582],"together":[583],"each":[590,862],"drug,":[591],"translated":[592],"into":[593],"changes":[594],"patient-related":[596,870],"quality":[597,630,732,760],"life.":[599,734],"Moreover,":[600],"given":[601],"relatively":[603],"short":[604],"duration":[605],"trials,":[607,804],"impact":[609,777],"immunosuppressants":[613,646],"on":[614,643,648,651,699,780,852],"remains":[621,677],"uncertain.":[622],"absence":[624],"outcome":[628,664],"life":[632,762],"from":[633,653],"trial":[634,655],"data":[635,846,851],"makes":[636],"assessment":[637],"contingent":[647],"modelling":[649,676],"based":[650,698],"extrapolations":[652],"outcomes.":[656,837],"choice":[658],"most":[661],"appropriate":[662],"function)":[673],"such":[675,730,805],"matter":[679],"scientific":[683],"debate.":[684],"decision":[686],"meta-model":[693],"this":[695,725],"report":[696],"findings":[701],"systematic":[704],"literature":[708],"predictors":[710],"outcome.":[714],"very":[717],"small":[718],"proportion":[719],"assessed":[727],"patient-focused":[728],"as":[731,806],"Since":[735],"have":[738],"benefits":[741,751],"specific":[743],"side-effects,":[744],"balance":[746],"harms":[749],"could":[752],"best":[753],"quantified":[755],"through":[756],"future":[757,767,803],"measures.":[763],"design":[765],"should":[769,864],"considered":[771],"view":[774],"particular":[781],"transplant":[783,857],"groups,":[784],"particularly":[785],"higher":[786],"risk":[787],"individuals":[788],"children.":[790],"Finally,":[791],"there":[792],"is":[793,840],"reporting":[798],"methodological":[800],"details":[801],"method":[808],"randomisation":[810],"allocation":[812],"concealment.":[813],"A":[814],"number":[815],"issues":[817],"exist":[818],"around":[819],"registry":[820,845],"data,":[821],"example":[823],"multiple":[827],"regimens":[829],"An":[838],"option":[839],"observational":[844],"including,":[847],"if":[848],"possible,":[849],"prospective":[850],"all":[853],"consecutive":[854],"UK":[855],"patients.":[858],"Data":[859],"capture":[860],"include":[865],"regimens,":[867],"demographics.":[874]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1994032445","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
